Quantcast

Latest Biological therapy for inflammatory bowel disease Stories

2011-05-10 09:00:00

BRUSSELS, May 10, 2011 /PRNewswire/ -- UCB announced today results from a post hoc analysis of the RAPID 1 study published in the Journal of Rheumatology. The results suggest moderate to severe rheumatoid arthritis (RA) patients treated with Cimzia® (certolizumab pegol), the only approved PEGylated anti-TNF, together with methotrexate (MTX), achieved a rapid response associated with improved long-term outcomes one year after treatment began. "These results are consistent...

2010-08-05 16:18:43

Biological agents may play an important role in maintaining remission in Crohn's disease, according to two new studies in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute. "Post-surgical recurrence of Crohn's disease occurs very frequently. Unfortunately, none of the traditional drugs used to treat the naturally occurring disease has really shown a clear-cut benefit in this situation," said Dario R. Sorrentino, MD,...

2010-04-19 10:18:32

Cystic fibrosis (CF) is the most common life-threatening autosomal recessive disease in Caucasian children; it has an incidence of 1 case in every 2500 children born alive. CF involves an anomalous function of the exocrine glands, caused by a mutation of a gene (cystic fibrosis transmembrane conductance regulator, CFTR) located on chromosome 7, which codes for a protein involved in ion transport through the cell membrane. Pulmonary complications are the most common causes of mortality, but...

2005-12-07 17:57:54

NEW YORK (Reuters Health) - Treatment of moderate-to-severe active ulcerative colitis, a severe inflammatory disease of the colon, with the drug infliximab is associated with sustained clinical responses and intestinal healing, according to results of two studies reported in The New England Journal of Medicine. Infliximab, an antibody that binds to an inflammatory protein, is effective for treatment of Crohn's disease, Dr. William J. Sandborn, from Mayo Clinic in Rochester, Minnesota,...

2005-09-01 00:15:36

Bethesda, Maryland (Sept. 1, 2005) "“ According to two studies published today in the American Gastroenterological Association (AGA) journal Gastroenterology, people with inflammatory bowel disease are more prone to developing severe disorders of the respiratory and nervous systems. The studies found an increase in the prevalence of asthma, arthritis, chronic renal disease, multiple sclerosis and psoriasis, among other disorders. "These studies remind us that the effects of...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.